ClinicalTrials.gov
ClinicalTrials.gov Menu

Double-Blind Randomized Controlled Trial for the Evaluation of a Novel Adaptive Attention Training in Healthy Adolescents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03213613
Recruitment Status : Not yet recruiting
First Posted : July 11, 2017
Last Update Posted : May 18, 2018
Sponsor:
Collaborator:
How I Decide Foundation
Information provided by (Responsible Party):
University of California, San Francisco

Brief Summary:
This project will evaluate the neuro-cognitive outcomes of a novel, adaptive attention training in a healthy adolescent population.

Condition or disease Intervention/treatment Phase
Healthy Adolescents Behavioral: Adaptive Attention Training Behavioral: Active Control Behavioral: Low-dose Adaptive Attention Training Not Applicable

Detailed Description:
Aspects of cognitive control, such as attention and working memory, are critical for successful goal-directed behavior. Importantly, variability in cognitive control abilities can influence real-world functioning, such as scholastic success in children and adolescents. The primary goal of this project is to examine the outcomes of a novel, adaptive attention training that primarily targets aspects of sustained attention and secondarily targets delayed gratification in adolescents. As such, the investigators will validate the feasibility and efficacy of this novel training in a randomized controlled trial (RCT) study. Specifically, healthy adolescents (age 12-16 years old) will be recruited for a longitudinal experiment in which they are randomly assigned to the adaptive attention training group ('Engage') or one of two expectancy-matched control groups. Depending on the assigned group, participants will complete 1 hour (low-dose control group) or 15 hours ('Engage' and active control groups) of training as well as pre-, post- and follow-up assessments of cognitive, neural, and behavioral measures. We hypothesize that completion of 'Engage' training will result in enhancement of fronto-parietal control functions that underlie sustained attention and suppression of ventral-striatal reward impulses, ultimately improving these abilities in a healthy adolescent population.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: Double-Blind Randomized Controlled Trial for the Evaluation of a Novel Adaptive Attention Training in Healthy Adolescents
Estimated Study Start Date : June 1, 2018
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : June 30, 2020

Arm Intervention/treatment
Experimental: Adaptive Attention Training
The training group will engage in 15 hours of at-home training on a novel iPad-based adaptive attention training program ('Engage'). Individuals will complete thirty 30-minute sessions over six weeks. Training compliance and performance data (accuracies and reaction times) will be continuously monitored remotely and analyzed over secure online servers to ensure that participants are completing training as scheduled and to deal with any unexpected road-blocks in training.
Behavioral: Adaptive Attention Training
The training is comprised of a time-based titration of rich audiovisual and sparse audio interactive environments. Training progressively transitions the participants from an immersive and rapid reward setting to a less immersive, sensory impoverished, and slower reward setting. Further, the participants' actions require delayed gratification decisions to accomplish play in the sparse setting, building fronto-parietal control through sustained attention and suppression of ventral-striatal reward impulses.

Placebo Comparator: Active Control
The active control group will engage in 15 hours of at-home training on an iPad game ('Boing'). Individuals will complete game play for the same number of hours as the training group to control for the effects of computer exposure and interaction, contact with research personnel, and monetary rewards. Compliance will be monitored similarly to the adaptive attention training group.
Behavioral: Active Control
Participants in the expectancy-matched active control group will play a visuo-spatial iPad game, in which players use their finger to move an object to different successive square platforms. Expectancy matching to the adaptive attention training was pre-confirmed in 121 participants (18-20 years of age), using targeted surveys on MTurk about their expectations of either training exposure on our specific outcome measures. To balance expectations of potential benefits, this group will receive identical recruitment and experimental instructions as the adaptive attention training group.

Placebo Comparator: Low-dose Adaptive Attention Training
The low-dose training group will engage in 1 hour of at-home training on 'Engage'. Individuals will complete two 30-minute sessions at the beginning and middle of a six-week period. Compliance will be monitored similarly to the adaptive attention training group.
Behavioral: Low-dose Adaptive Attention Training
Participants in the low-dose training group will play a reduced number of sessions as the Adaptive Attention Training group. Specifically, they will train for two 30-minute sessions at the start and middle of a six-week period. To balance expectations of potential benefits, this group will receive identical recruitment and experimental instructions as the adaptive attention training group.




Primary Outcome Measures :
  1. Test of Variables of Attention (TOVA), visual form, change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]

Secondary Outcome Measures :
  1. Delay Discounting task, change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]

Other Outcome Measures:
  1. Filter task, change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For assessment of visual working memory with distraction

  2. Attend Ignore Distractor (AID) task, change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For assessment of visual working memory with distraction during memory delay

  3. Adaptive Cognitive Evaluation (ACE) neuropsychological battery, change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For global assessment of cognitive control

  4. EEG-based neural processing of stimuli in Test of Variables of Attention (TOVA), visual form, change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For assessment of neural processing underlying sustained attention

  5. fMRI-based blood oxygen level dependent (BOLD) signal processing during Delay Discounting task, change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For assessment of neural processing underlying delay discounting

  6. EEG-based neural processing of stimuli in Filter task, change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For assessment of neural processing underlying visual working memory with distraction

  7. EEG-based neural processing of stimuli in Attend Ignore Distractor (AID) task, change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For assessment of neural processing underlying visual working memory, with distraction during memory delay

  8. Resting-state functional connectivity (functional MRI and EEG), change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For neural assessment of intrinsic functional connections between brain regions

  9. Structural connectivity (diffusion tensor imaging, DTI), change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For neural assessment of structural (white matter) connections between brain regions

  10. Mindful Attention Awareness Scale (MAAS), change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For behavioral assessment of mindful attention awareness

  11. Warwick-Edinburgh Mental Wellbeing-Scale, change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For behavioral assessment of mental wellbeing

  12. Torrance Tests of Creative Thinking, change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention. ]
    For assessment of visual creativity

  13. Child Self-Control Rating Scale (parent and teacher ratings), change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For behavioral assessment of self-control

  14. Stanford Education Assessment (SEA) battery, change from baseline [ Time Frame: Change from baseline at completion of practice on assigned intervention and at 6 months follow-up post-intervention. ]
    For assessment of math and reading skills



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy right-handed children, age 12-16 years old
  • No ADHD status (verified with the Vanderbilt ADHD Parent form)
  • Willing and able to undergo MRI and EEG procedures

Exclusion Criteria:

  • Current psychotropic medications
  • Current diagnosis of any axis I psychiatric disorder
  • History of seizure disorder or seizure episodes over the last 2 years
  • Motor/perceptual handicap that prevents computer use

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03213613


Locations
United States, California
UCSF Neuroscape Not yet recruiting
San Francisco, California, United States, 94158
Contact: Jessica Schachtner, BS       NeuroscapeAttentionStudy@ucsf.edu   
Principal Investigator: Courtney L Gallen, PhD         
Principal Investigator: Jyoti Mishra, PhD         
Principal Investigator: Adam Gazzaley, MD, PhD         
Sponsors and Collaborators
University of California, San Francisco
How I Decide Foundation
Investigators
Principal Investigator: Courtney Gallen, PhD University of California, San Francisco

Responsible Party: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT03213613     History of Changes
Other Study ID Numbers: P0505751
First Posted: July 11, 2017    Key Record Dates
Last Update Posted: May 18, 2018
Last Verified: May 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University of California, San Francisco:
Teen health
Teen development
Adolescent development
Memory
Attention
Reward processing